JOHN NEIS
CIK 1167426 · last filed 2026-07-08
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$25
Companies
6
Total Filings
23
Lifetime Open-Market Net
-$105.70M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CLRB | Director | 10 | $2.50 | $25 | -$732 | 7 | 2026-07-08 |
| Cellectar Biosciences, Inc. (CLRBZ) Delisted | Director | 626,103 | $0.12 | $74.5K | $488.9K | 8 | 2021-03-19 |
| Cellectar Biosciences, Inc. (CLRB.W) Delisted | Director | 493,715 | — | — | $1.01M | 4 | 2016-07-06 |
| Cellectar Biosciences, Inc. (CLRB.Z) Delisted | Director | 297,984 | — | — | $497.7K | 1 | 2016-04-21 |
| TomoTherapy Inc (TOMO) Delisted | Director | 926,160 | — | — | -$1.00M | 1 | 2008-02-28 |
| TomoTherapy Inc (TTPY) Delisted | Director | 983,194 | — | — | -$106.69M | 2 | 2007-10-18 |
Recent Filings · Page 3 of 3
23 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2008-02-28 | TomoTherapy Inc (TOMO) Delisted | Mixed | −1,585,242 | -$1.00M | EDGAR |
| 2007-10-18 | TomoTherapy Inc (TTPY) Delisted | Sell (S) | −3,527,208 | -$78.48M | EDGAR |
| 2007-05-15 | TomoTherapy Inc (TTPY) Delisted | Sell (S) | −1,484,848 | -$28.21M | EDGAR |
Showing 21–23 of 23
Prev
Page 3 of 3
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.